We serve Alloc-L-Lys(Fmoc)-OH CAS:186350-56-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | White to off-white powder | White powder |
| Purity (HPLC) | ≥95% | 98.6% |
| Optical Purity | ≤0.5% D-enantiome | ND |
| Clarity of solution | 0.3 gram in 2ml DMF clear solution | Conform |
| Melting Point | 120.0-125.0℃ | 120.6-122.5℃ |
| Loss on drying | ≤1.0% (60oC,2h) | 0.2% |
| Water Content (K. F.) | ≤1.0% | 0.6% |
| Specific Rotation | -9.0±1.0°(c=2,DMF) | -8.4° |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like Alloc-L-Lys(Fmoc)-OH chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-ALPHA-ALLYLOXYCARBONYL-N-EPSILON-(9-FLUORENYLMETHYLOXYCARBONYL)-L-LYSINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-ALPHA-ALLYLOXYCARBONYL-N-EPSILON-(9-FLUORENYLMETHYLOXYCARBONYL)-L-LYSINE Use and application,N-ALPHA-ALLYLOXYCARBONYL-N-EPSILON-(9-FLUORENYLMETHYLOXYCARBONYL)-L-LYSINE technical grade,usp/ep/jp grade.
Related News: APIs are generally manufactured through a variety of processes that include.1-Phenyl-4-phenylamino-1,5-dihydro-pyrrol-2-one manufacturer People should also avoid having visitors, although it is okay for family and friends to drop off parcels or medicines, for example.1-(6-chloronaphthalen-2-yl)-N-(4-(dimethylcarbamoyl)phenyl)-3-methyl-1H-pyrazole-5-carboxamide supplier People should also avoid having visitors, although it is okay for family and friends to drop off parcels or medicines, for example.3,3-Dimethylallyl-3,5-dinitrobenzoat vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.
